Recommendations for follow-up of colorectal cancer survivors

• Published in: Clinical & translational oncology Vol. 21; no. 10; pp. 1302 - 1311
• Main Authors: Vera, R., Aparicio, J., Carballo, F., Esteva, M., González-Flores, E., Santianes, J., Santolaya, F., Fernández-Cebrián, J. M.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.10.2019
• Subjects: Antineoplastic Agents - adverse effects; Cancer Survivors; Carcinoembryonic Antigen - analysis; Colonic Neoplasms - diagnosis; Colonic Neoplasms - pathology; Colonic Neoplasms - therapy; Colonoscopy; Continuity of Patient Care; Female; Humans; Liver Neoplasms - diagnostic imaging; Liver Neoplasms - secondary; Lung Neoplasms - diagnostic imaging; Lung Neoplasms - secondary; Male; Medicine; Medicine & Public Health; Neoplasm Recurrence, Local - diagnosis; Neoplasm Recurrence, Local - prevention & control; Neoplasm Staging; Oncology; Oxaliplatin - adverse effects; Patient Care Team; Population Surveillance; Postoperative Complications; Primary Prevention; Radiotherapy - adverse effects; Rectal Neoplasms - diagnosis; Rectal Neoplasms - pathology; Rectal Neoplasms - therapy; Secondary Prevention; Sexual Dysfunction, Physiological - etiology; Special Article; Time Factors; Cancer survivors; Surveillance; Treatment sequelae; Monitoring; Care coordination; Quality of life
• ISSN: 1699-048X; 1699-3055
• DOI: 10.1007/s12094-019-02059-1

Colorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number of patients who survive for prolonged periods of time. In addition, despite recurrences, improved survival following metastasis resection is likewise on the rise. This underscores the importance of carrying out follow-up programmes even in low-risk patients for the early detection of recurrence. The main objective of this article is to provide a set of recommendations for optimising the follow-up of CRC survivors as well as for managing the sequelae that result from either pharmacological or surgical treatment.